<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR40_25">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <collab>The IMpact-RSV Study Group</collab>
  </person-group>
  <article-title>Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants</article-title>
  <source>Pediatrics</source>
  <year>1998</year>
  <volume>102</volume>
  <issue>3</issue>
  <fpage>531</fpage>
  <lpage>7</lpage>
  <pub-id pub-id-type="doi">10.1542/peds.102.3.531</pub-id>
 </element-citation>
</ref>
